Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Anxiety
• Autism Spectrum Disorder
• Bipolar Disorder
• Cancer
• Corona Virus Infection
• Coronavirus
• Covid19
• Crohn Disease
• Epilepsy
• Fibromyalgia
• Glaucoma
• HIV Aids
• Hepatitis C
• Inflammatory Bowel Diseases
• Insomnia
• Major Depressive Disorder
• Multiple Sclerosis
• Opioid Use Disorder
• Pain
• Pain Due to Injury
• Pain Due to Trauma
• Pain Syndrome
• Parkinson Disease
• Post-traumatic Stress Disorder
• Sars-cov Infection
• Seizures
• Sickle Cell Disease
• Tourette Syndrome
• Traumatic Brain Injury
• Traumatic Encephalopathy
• Ulcerative Colitis

Snippet

Sponsor: OMNI Medical Services, LLC | Conditions: Chronic Pain, Chronic Pain Syndrome | Phase 2 | Status: UNKNOWN